Test Price
2,800 AED✅ Home Collection Available
CSRP3 Gene Dilated Cardiomyopathy Type 1M Genetic Test – 2,800 AED – DNA Labs UAE
Executive Summary & Core Metrics
Diagnostic Precision: 99.9% analytical sensitivity and specificity via ISO 9001:2015-accredited NGS laboratory, ensuring clinically actionable results for cardiovascular genetic risk assessment.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection – available daily from 8 AM to 11 PM. Samples (whole blood, FTA card, or extracted DNA) are transported under ISO-certified cold chain for optimal DNA preservation.
Clinical Guidance: Telephonic post-test consultation with a cardiologist or genetic counsellor to interpret the report and integrate findings into your cardiovascular care plan.
Insurance & Billing: Direct insurance verification and pre‑approval support via WhatsApp at +971 54 548 8731. We partner with all major UAE networks.
Test Overview & Methodology
This test analyses the CSRP3 gene via Next-Generation Sequencing (NGS) to identify pathogenic variants associated with dilated cardiomyopathy type 1M, a heritable heart muscle disease that can lead to heart failure and arrhythmias. The test covers all coding exons and splice sites with deep coverage for confident variant detection.
| Feature | Our Test (NGS) | Traditional Sanger Sequencing |
|---|---|---|
| Analytical Sensitivity | >99.9% for single nucleotide variants and indels in CSRP3 | ~99% for targeted regions, may miss large deletions/duplications |
| Turnaround Time | 3–4 weeks | 6–8 weeks (gene-by-gene analysis) |
| Clinical Utility | Simultaneous coverage of all coding exons and splice sites; suitable for familial cascade testing | Limited to predefined amplicons; often requires sequential testing |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh – Consultant Medical Genetics (DHA Registration ID: 9294403) “A positive CSRP3 mutation result does not stand alone; it must be correlated with echocardiography, ECG, and family history. This test empowers families to make informed decisions about surveillance and early intervention, but it is not a substitute for regular cardiology follow‑up.”
Medication Safety Advisory
Do not discontinue or adjust any prescribed heart failure or anti‑arrhythmic medication without consulting your treating cardiologist. This genetic test provides risk information; it does not replace pharmacologic management.
Exclusion Criteria & Emergency Red Flags
- Exclusions: This test is not indicated for acute myocarditis diagnosis or in patients with decompensated heart failure requiring critical care. It cannot be performed on children below the age of consent without court‑approved guardian authorization in line with UAE Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Emergency Red Flags: If you experience sudden chest pain, syncope (fainting), severe shortness of breath, or palpitations, seek immediate medical attention at the nearest emergency department. Do not wait for genetic test results.
- Pre‑Test Requirement: A genetic counselling session is mandatory before sample collection to document a three‑generation pedigree and obtain informed consent, in accordance with UAE Federal Decree-Law No. 4 of 2016 and Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL).
Patient FAQ & Clinical Guidance
1. What does the CSRP3 genetic test diagnose?
The test identifies pathogenic variants in the CSRP3 gene that cause dilated cardiomyopathy type 1M, an inherited condition weakening the heart muscle. Confirming the genetic cause helps guide family screening and early interventions.
2. How long do results take and what sample is required?
Results are available within 3–4 weeks from a single blood draw, FTA card, or previously extracted DNA. Our VIP Mobile Phlebotomy team collects the sample at your home between 8 AM and 11 PM, seven days a week.
3. Will my health insurance cover this test?
Many UAE insurers cover genetic testing for cardiomyopathy when medically indicated; our team verifies coverage and obtains pre‑approval before your appointment. Contact us via WhatsApp at +971 54 548 8731 for a coverage check.
UAE Regulatory & Data Privacy Adherence
This test is performed at DNA Labs UAE, a DHA-licensed facility (License No. 1143) operating under the strictest UAE data protection and health information frameworks.
- Data Privacy: Compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL).
- Health Information Security: Adheres to Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Patient Consent & Safety: Governed by Federal Decree-Law No. 4 of 2016 on Medical Liability.
Your genetic data is encrypted, stored securely, and never shared without your explicit consent. All procedures comply with international standards for genetic testing and confidentiality.
Clinical & Logistical Metadata
| Test Name | CSRP3 Gene Dilated Cardiomyopathy Type 1M Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Whole blood (EDTA), FTA card, or extracted DNA |
| Methodology Used | Next-Generation Sequencing (NGS) – Full gene sequencing with deletion/duplication analysis |
| ICD-10-CM Code | I42.0 (Dilated cardiomyopathy) |
| LOINC Code | 21685-1 (Gene mutations tested for in Blood or Tissue by Molecular genetics method) |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians